CN105012686A - Medicinal preparation for treating stress-related diseases of Chinese soft-shelled turtles and preparing method thereof - Google Patents

Medicinal preparation for treating stress-related diseases of Chinese soft-shelled turtles and preparing method thereof Download PDF

Info

Publication number
CN105012686A
CN105012686A CN201510506898.4A CN201510506898A CN105012686A CN 105012686 A CN105012686 A CN 105012686A CN 201510506898 A CN201510506898 A CN 201510506898A CN 105012686 A CN105012686 A CN 105012686A
Authority
CN
China
Prior art keywords
wiegmann
radix
trionyx sinensis
vitamin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510506898.4A
Other languages
Chinese (zh)
Other versions
CN105012686B (en
Inventor
黎林英
周桂荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUZHOU CITY JINGTAI TURTLE PROFESSIONAL COOPERATIVES
Original Assignee
WUZHOU CITY JINGTAI TURTLE PROFESSIONAL COOPERATIVES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUZHOU CITY JINGTAI TURTLE PROFESSIONAL COOPERATIVES filed Critical WUZHOU CITY JINGTAI TURTLE PROFESSIONAL COOPERATIVES
Priority to CN201510506898.4A priority Critical patent/CN105012686B/en
Publication of CN105012686A publication Critical patent/CN105012686A/en
Application granted granted Critical
Publication of CN105012686B publication Critical patent/CN105012686B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a medicinal preparation for treating the stress-related diseases of Chinese soft-shelled turtles and a preparing method thereof. The medicinal preparation is medicine powder comprising, by weight, 7% to 13% of uncaria rhynchophylla, 7% to 13% of rhizoma corydalis, 5% to 11% of jujube kernels, 5% to 11% of salvia miltiorrhiza, 5% to 11% of radix bupleuri, 5% to 11% of radix rehmanniae,2% to 8% of motherwort herbs, 2% to 8% of medical stone, 5% to 11% of rhizoma polygonati, 5% to 11% of astragalus membranaceus, 5% to 11% of herba epimedii, 5% to 11% of schisandra chinensis, 2% to 8% of liquorice and 0.5% to 1.5% of vitamins C, wherein the sum of the components is 100%. The preparing method of the medicinal preparation includes the steps that the vitamins C are weighed according to the weight percent and pulverized; the medicinal materials are weighed according to the weight percents to be mixed and smashed to pass through a 80-mesh sieve, the product is dried to be mixed with the vitamins C powder, and the medicinal preparation is obtained. The medicinal preparation for treating the stress-related diseases of Chinese soft-shelled turtles has the advantages of being good in treatment effect and free of medicine residuals when used for treating the stress-related diseases of Chinese soft-shelled turtles.

Description

A kind ofly treat pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical preparation, more particularly, particularly relate to a kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease, the invention still further relates to the preparation method of this kind of pharmaceutical preparation.
Background technology
In Trionyx sinensis (Wiegmann) breeding process, when Trionyx sinensis (Wiegmann) sense organ to extraneous there is certain environment change time, Trionyx sinensis (Wiegmann) body stimulates to external world can produce corresponding specific variations, and this change is that Trionyx sinensis (Wiegmann) attempts to adapt to the change of internal and external environment and the non-specific change that produces.The Trionyx sinensis (Wiegmann) stress disease that so-called " environment-stress " factor causes is exactly the nonspecific reaction that Trionyx sinensis (Wiegmann) is subject to the stimulation generation of external environment condition change.Usual Trionyx sinensis (Wiegmann) stress disease shows as: under the working condition of intensive culture, especially during Raised turtle as there is the ecological ragime of high temperature, high density, high pollution, or when Trionyx sinensis (Wiegmann) Trionyx sinensis Wiegmann is faced with far beyond its stressors at aspects such as the contingent environment in natural life area, physiology and immunity, easily produce stress disease.As under the condition of high temperature, high pollution and severe depletion of oxygen, Trionyx sinensis (Wiegmann) can be had dizzy spells, stress is strong, often shows as and emerges, head rocks on the water surface, is far from being tranquil, and the time one is long, will produce neurotoxic, occur that forelimb bends the symptom that can not stretch, mortality rate is more than 20%.Stress disease makes the fertility performance of Trionyx sinensis (Wiegmann) decline, minimizing of ingesting, and produces larger adverse influence to feed conversion rate, the speed of growth, survival rate etc.Mainly take vitamin C during traditional treatment Trionyx sinensis (Wiegmann) stress disease, and it is undesirable singly to use this kind of medicine to carry out therapeutic effect.Therefore, how to find a kind of pharmaceutical preparation to treat Trionyx sinensis (Wiegmann) stress disease, make its therapeutic effect better, and drug residue free, become problem demanding prompt solution.
Summary of the invention
The object of the present invention is to provide the pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease, this kind of pharmaceutical preparation has to treatment Trionyx sinensis (Wiegmann) stress disease that therapeutic effect is good, the feature of drug residue free.
Another object of the present invention is to provide a kind of preparation method of said medicine preparation.
Last technical scheme of the present invention is as follows:
A kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease, it is the medicated powder be made up of the medicine material of following weight percentage ratio, Ramulus Uncariae Cum Uncis 7 ~ 13%, Rhizoma Corydalis 7 ~ 13%, Semen Ziziphi Spinosae 5 ~ 11%, Radix Salviae Miltiorrhizae 5 ~ 11%, Radix Bupleuri 5 ~ 11%, the Radix Rehmanniae 5 ~ 11%, Herba Leonuri 2 ~ 8%, Maifanitum 2 ~ 8%, Rhizoma Polygonati 5 ~ 11%, the Radix Astragali 5 ~ 11%, Herba Epimedii 5 ~ 11%, Fructus Schisandrae Chinensis 5 ~ 11%, Radix Glycyrrhizae 2 ~ 8%, vitamin C 0.5 ~ 1.5%, each component sum is 100%.
Further, described drug weight degree is: Ramulus Uncariae Cum Uncis 10%, Rhizoma Corydalis 10%, Semen Ziziphi Spinosae 8%, Radix Salviae Miltiorrhizae 8%, Radix Bupleuri 8%, the Radix Rehmanniae 8%, Herba Leonuri 5%, Maifanitum 5%, Rhizoma Polygonati 8%, the Radix Astragali 8%, Herba Epimedii 8%, Fructus Schisandrae Chinensis 8%, Radix Glycyrrhizae 5%, vitamin C 1%.
Further, described medicated powder granularity is less than 80 orders.
After of the present invention, a technical scheme is as follows:
Treat a preparation method for the pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease, comprise following preparation process:
(1) vitamin C medicated powder is pulverized into after taking vitamin C by weight percentage;
(2) precentagewise mixes after taking these raw material of Chinese medicine of Ramulus Uncariae Cum Uncis, Rhizoma Corydalis, Semen Ziziphi Spinosae, Radix Salviae Miltiorrhizae, Radix Bupleuri, the Radix Rehmanniae, Herba Leonuri, Maifanitum, Rhizoma Polygonati, the Radix Astragali, Herba Epimedii, Fructus Schisandrae Chinensis and Radix Glycyrrhizae;
(3) mixed Chinese medicine is carried out pulverization process;
(4) Chinese medicine powder after pulverizing is crossed 80 mesh sieves;
(5) Chinese medicine powder after screening is carried out microwave drying, then after mixing homogeneously with vitamin C medicated powder and get final product.
Further, in step (5), drying time is 20 ~ 40 minutes.
Compared with prior art, the beneficial effect that the present invention has is:
A kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention, except vitamin C, all the other all select Chinese medicine material, do not have the Drug resistance of chemical agent, drug resistance and poisoning residual.Ramulus Uncariae Cum Uncis in preparation has heat clearing away suppressing the hyperactive liver, the effect of the arresting convulsion that relieves dizziness, high fever, infantile convulsions, epilepsy, etc.; Rhizoma Corydalis is warm in nature, acrid in the mouth is bitter, has effect of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain; Semen Ziziphi Spinosae sugariness is put down, and has nourishing the liver, mind calming, calms the nerves, effect of arresting sweating; Radix Salviae Miltiorrhizae energy promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Radix Bupleuri have induce sweat bring down a fever, effect of dispersing the stagnated live-QI to relieve the stagnation of QI; The Radix Rehmanniae has effect of clearing away heat and cooling blood; Herba Leonuri can be invigorated blood circulation; Maifanitum contains several mineral materials, has oxygen lack resistant function; Rhizoma Polygonati has boosting qi and nourishing yin, spleen invigorating, lung moistening, effect of kidney tonifying; The icariin contained in Herba Epimedii, can promote hemopoietic function, immunologic function and bone metabolism, has antibacterial, the effect such as antiviral, antiinflammatory; Fructus Schisandrae Chinensis energy energy supplementing QI for promoting the production of body fluid, the kidney invigorating nourish heart, it is astringent or styptic treatment for spontaneous sweating to restrain, and build up one's resistance to disease; The Radix Astragali is QI invigorating good medicine, builds up resistance.The medicament of this formula is used for the treatment of Trionyx sinensis (Wiegmann) stress disease, and therapeutic effect is good, is generally connected to feed by the Trionyx sinensis (Wiegmann) of morbidity and just can cure for 3 ~ 4 days.
A kind of preparation method for the treatment of the pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease of the present invention, vitamin C medicated powder is pulverized into after taking vitamin C by weight percentage, mix after taking various Chinese medicine by weight percentage, again mixed Chinese medicine pulverized and cross 80 mesh sieves, after microwave drying is mixed homogeneously with vitamin C medicated powder again and get final product, effective ingredient when this pharmaceutical preparation decocts in Chinese medicine can better be dissolved in water, the Trionyx sinensis (Wiegmann) that after being mixed with medicinal liquid by feedstuff, feeding is sick, facilitates its edible absorption.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme of the present invention is described in further detail, but does not form any limitation of the invention.
Embodiment 1
Treat a pharmaceutical preparation for Trionyx sinensis (Wiegmann) stress disease, each weight percentages of components is: Ramulus Uncariae Cum Uncis 7%, Rhizoma Corydalis 13%, Semen Ziziphi Spinosae 5%, Radix Salviae Miltiorrhizae 11%, Radix Bupleuri 5%, the Radix Rehmanniae 11%, Herba Leonuri 2%, Maifanitum 8%, Rhizoma Polygonati 5%, the Radix Astragali 11%, Herba Epimedii 5%, Fructus Schisandrae Chinensis 11%, Radix Glycyrrhizae 5%, vitamin C 1%.
The preparation method of pharmaceutical preparation of the present invention, comprises the steps:
(1) vitamin C medicated powder is pulverized into after taking vitamin C by weight percentage.Select common tablet vitamin C, and this vitamin C tablet easily pulverizes, easily water-soluble, do not need through pulverization process.
(2) precentagewise mixes after taking these raw material of Chinese medicine of Ramulus Uncariae Cum Uncis, Rhizoma Corydalis, Semen Ziziphi Spinosae, Radix Salviae Miltiorrhizae, Radix Bupleuri, the Radix Rehmanniae, Herba Leonuri, Maifanitum, Rhizoma Polygonati, the Radix Astragali, Herba Epimedii, Fructus Schisandrae Chinensis and Radix Glycyrrhizae.The medicament be prepared from of being arranged in pairs or groups by this few taste medical material is used for the treatment of Trionyx sinensis (Wiegmann) stress disease, makes therapeutic effect good.
(3) mixed Chinese medicine is carried out pulverization process, each Chinese medicine mixed effect after pulverizing is better.Mixed Chinese medicine is broken into powder, and when medicated powder is decocted with water, effective ingredient is better dissolved in water, so that ill Trionyx sinensis (Wiegmann) better absorbs.
(4) Chinese medicine powder after pulverizing is crossed 80 mesh sieves, to guarantee that the granule of Chinese medicine powder is less than 80 orders.
(5) Chinese medicine powder after screening is carried out microwave drying, then after mixing homogeneously with vitamin C medicated powder and get final product.Wherein, drying time is 20 ~ 40 minutes.Microwave drying carries out usually in microwave tunnel, can control suitable microwave intensity, reaches quick-drying object.By Chinese medicine is carried out microwave drying treatment, make Chinese medicine drier conveniently deposit and microwave also with bactericidal action, killing bacteria can not needed to increase sterilization steps in addition.
A kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention, except vitamin C, all the other all select Chinese medicine material, do not have the Drug resistance of chemical agent, drug resistance and poisoning residual.Wherein, Rhizoma Corydalis in medicament, Radix Salviae Miltiorrhizae and Herba Leonuri have the effect of invigorating blood circulation, the soothing the liver suppressing the hyperactive liver of Ramulus Uncariae Cum Uncis in medicament, Semen Ziziphi Spinosae and Radix Bupleuri energy, Rhizoma Polygonati, the Radix Astragali, Herba Epimedii and Fructus Schisandrae Chinensis can improve immunity, Maifanitum has the effect of anti-hypoxia, the medicament of this formula is used for the treatment of Trionyx sinensis (Wiegmann) stress disease, and therapeutic effect is good, is generally connected to feed by the Trionyx sinensis (Wiegmann) of morbidity and just can cure for 3 ~ 4 days.
Using method: when finding that the Trionyx sinensis (Wiegmann) in Trionyx sinensis Wiegmann pond suffers from stress disease, claimed by medicated powder 80g as a standard part, a kind of pharmaceutical preparation one standard part medicated powder for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention is put in marmite by every only ill Trionyx sinensis (Wiegmann) at every turn, to add in 150ml water slow fire boiling after 2 hours, taking liquid removes slag and cools, be mixed into after 4% Trionyx sinensis (Wiegmann) feedstuff stirs and throw something and feed, sooner or later respectively once, within 3 ~ 4 days, cure.
Embodiment 2
Treat a pharmaceutical preparation for Trionyx sinensis (Wiegmann) stress disease, each weight percentages of components is: Ramulus Uncariae Cum Uncis 10%, Rhizoma Corydalis 10%, Semen Ziziphi Spinosae 8%, Radix Salviae Miltiorrhizae 8%, Radix Bupleuri 8%, the Radix Rehmanniae 8%, Herba Leonuri 5%, Maifanitum 5%, Rhizoma Polygonati 8%, the Radix Astragali 8%, Herba Epimedii 8%, Fructus Schisandrae Chinensis 8%, Radix Glycyrrhizae 5%, vitamin C 1%.
Preparation method is identical with embodiment 1 with using method.
Embodiment 3
Treat a pharmaceutical preparation for Trionyx sinensis (Wiegmann) stress disease, each weight percentages of components is: Ramulus Uncariae Cum Uncis 13%, Rhizoma Corydalis 7%, Semen Ziziphi Spinosae 11%, Radix Salviae Miltiorrhizae 5%, Radix Bupleuri 11%, the Radix Rehmanniae 5%, Herba Leonuri 8%, Maifanitum 2%, Rhizoma Polygonati 11%, the Radix Astragali 5%, Herba Epimedii 11%, Fructus Schisandrae Chinensis 5%, Radix Glycyrrhizae 5%, vitamin C 1%.
Preparation method is identical with embodiment 1 with using method.
Embodiment 4
Treat a pharmaceutical preparation for Trionyx sinensis (Wiegmann) stress disease, each weight percentages of components is: Ramulus Uncariae Cum Uncis 8%, Rhizoma Corydalis 12%, Semen Ziziphi Spinosae 6%, Radix Salviae Miltiorrhizae 10%, Radix Bupleuri 6%, the Radix Rehmanniae 10%, Herba Leonuri 3%, Maifanitum 7%, Rhizoma Polygonati 6%, the Radix Astragali 10%, Herba Epimedii 6%, Fructus Schisandrae Chinensis 10%, Radix Glycyrrhizae 4.5%, vitamin C 1.5%.
Preparation method is identical with embodiment 1 with using method.
Embodiment 5
Treat a pharmaceutical preparation for Trionyx sinensis (Wiegmann) stress disease, each weight percentages of components is: Ramulus Uncariae Cum Uncis 12%, Rhizoma Corydalis 8%, Semen Ziziphi Spinosae 7%, Radix Salviae Miltiorrhizae 9%, Radix Bupleuri 9%, the Radix Rehmanniae 7%, Herba Leonuri 7%, Maifanitum 3%, Rhizoma Polygonati 6%, the Radix Astragali 10%, Herba Epimedii 9%, Fructus Schisandrae Chinensis 7%, Radix Glycyrrhizae 5.5%, vitamin C 0.5%.
Preparation method is identical with embodiment 1 with using method.
Contrast test
Test site is selected in Jingtai, Wuzhou plant of Yang Bie Specialty Co-operative Organization and carries out.After in July, 2013, along with temperature raises, Trionyx Sinensis pond middle water level reaches 28 ~ 30 DEG C, and the Trionyx Sinensis part in Trionyx sinensis Wiegmann pond shows successively has dizzy spells, often show as and emerge, head rocks on the water surface, is far from being tranquil, and checks its health, find that whole body body surface is intact, immaculate, without ulcer, tentatively concludes that they suffer from stress disease.
Prevention and controls
Test, by substantially identical for two specifications, uses the Trionyx sinensis pond of identical water system, and the Trionyx sinensis (Wiegmann) quantity of cultivation is identical and the Trionyx sinensis Wiegmann pond that disease condition is also substantially identical is set as test Trionyx sinensis pond, and arranging No. 1 Trionyx sinensis Wiegmann pond is test group, and No. 2 Trionyx sinensis Wiegmann ponds are matched group.When on-test, record the number of ill Trionyx sinensis in 1, No. 2 Trionyx sinensis Wiegmann pond respectively.A kind of Chinese medicine preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention is used to treat in No. 1 Trionyx sinensis Wiegmann pond, getting 1 standard part medicated powder by every Trionyx sinensis (Wiegmann) in Trionyx sinensis Wiegmann pond is put in marmite, slow fire boiling is added in 150ml water after 2 hours by every 1 standard part medicated powder, taking liquid removes slag and cools, be mixed into after 4% Trionyx sinensis (Wiegmann) feedstuff stirs and throw something and feed, sooner or later each once, after being used in conjunction 3 days, observing and record the situation of Trionyx Sinensis in No. 1 Trionyx sinensis Wiegmann pond.No. 2 Trionyx sinensis Wiegmann ponds use merely vitamin C tablet to treat, add after vitamin C 3 ~ 4g takes vitamin C tablet by per kilogram feedstuff and pulverize into vitamin C medicated powder, put into after feedstuff stirs and throw something and feed, continuous 7 days, observe and record the situation of Trionyx Sinensis in No. 1 Trionyx sinensis Wiegmann pond.By as follows for the Trionyx sinensis (Wiegmann) therapeutic outcome comparable situation in 1, No. 2 Trionyx sinensis Wiegmann pond:
Results contrast after experimental group and matched group medication
According to data analysis in results contrast table after test group and contrast groups medicine, sick Trionyx sinensis Wiegmann healing time in No. 1 Trionyx sinensis Wiegmann pond is shorter than the sick Trionyx sinensis Wiegmann healing time in No. 2 Trionyx sinensis Wiegmann ponds, the sick Trionyx sinensis Wiegmann in No. 1 Trionyx sinensis Wiegmann pond after 3 days substantially the mental status, ingest and live all normal, whole ill Trionyx sinensis is cured, the sick Trionyx sinensis Wiegmann major part in No. 2 Trionyx sinensis Wiegmann ponds after 3 days spirit improves, ingest increase, Trionyx sinensis major part has sneaked into water-bed rest, and most of ill Trionyx sinensis takes a turn for the better; Sick Trionyx sinensis Wiegmann in No. 2 Trionyx sinensis Wiegmann ponds is treated and all cures afterwards for 7 days, and No. 1 Trionyx sinensis Wiegmann pond does not find new ill Trionyx sinensis yet.Comprehensive above relative analysis data draw, use a kind of Chinese medicine preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention to treat, therapeutic effect is better.
A kind of Chinese medicine preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease of the present invention is except vitamin C, and all the other all select Chinese medicine material, do not have the Drug resistance of chemical agent, drug resistance, and medicine can not be made residual on the body of Trionyx sinensis (Wiegmann).
The foregoing is only preferred embodiment of the present invention, all do within the scope of the spirit and principles in the present invention any amendment, equivalent to replace and improvement etc., all should be included within protection scope of the present invention.

Claims (5)

1. treat the pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease for one kind, it is characterized in that, it is the medicated powder be made up of the medicine material of following weight percentage ratio: Ramulus Uncariae Cum Uncis 7 ~ 13%, Rhizoma Corydalis 7 ~ 13%, Semen Ziziphi Spinosae 5 ~ 11%, Radix Salviae Miltiorrhizae 5 ~ 11%, Radix Bupleuri 5 ~ 11%, the Radix Rehmanniae 5 ~ 11%, Herba Leonuri 2 ~ 8%, Maifanitum 2 ~ 8%, Rhizoma Polygonati 5 ~ 11%, the Radix Astragali 5 ~ 11%, Herba Epimedii 5 ~ 11%, Fructus Schisandrae Chinensis 5 ~ 11%, Radix Glycyrrhizae 2 ~ 8%, vitamin C 0.5 ~ 1.5%, and each component sum is 100%.
2. a kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease according to claim 1, it is characterized in that, described drug weight degree is: Ramulus Uncariae Cum Uncis 10%, Rhizoma Corydalis 10%, Semen Ziziphi Spinosae 8%, Radix Salviae Miltiorrhizae 8%, Radix Bupleuri 8%, the Radix Rehmanniae 8%, Herba Leonuri 5%, Maifanitum 5%, Rhizoma Polygonati 8%, the Radix Astragali 8%, Herba Epimedii 8%, Fructus Schisandrae Chinensis 8%, Radix Glycyrrhizae 5%, vitamin C 1%.
3. a kind of pharmaceutical preparation for the treatment of Trionyx sinensis (Wiegmann) stress disease according to claim 1, is characterized in that, described medicated powder granularity is less than 80 orders.
4. a kind of preparation method for the treatment of the pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease described in claim 1 or 2, is characterized in that, comprise following preparation process:
(1) vitamin C medicated powder is pulverized into after taking vitamin C by weight percentage;
(2) precentagewise mixes after taking these raw material of Chinese medicine of Ramulus Uncariae Cum Uncis, Rhizoma Corydalis, Semen Ziziphi Spinosae, Radix Salviae Miltiorrhizae, Radix Bupleuri, the Radix Rehmanniae, Herba Leonuri, Maifanitum, Rhizoma Polygonati, the Radix Astragali, Herba Epimedii, Fructus Schisandrae Chinensis and Radix Glycyrrhizae;
(3) mixed Chinese medicine is carried out pulverization process;
(4) Chinese medicine powder after pulverizing is crossed 80 mesh sieves;
(5) Chinese medicine powder after screening is carried out microwave drying, then after mixing homogeneously with vitamin C medicated powder and get final product.
5. a kind of preparation method for the treatment of the pharmaceutical preparation of Trionyx sinensis (Wiegmann) stress disease according to claim 4, is characterized in that, in step (5), drying time is 20 ~ 40 minutes.
CN201510506898.4A 2015-08-18 2015-08-18 A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease Active CN105012686B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510506898.4A CN105012686B (en) 2015-08-18 2015-08-18 A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510506898.4A CN105012686B (en) 2015-08-18 2015-08-18 A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease

Publications (2)

Publication Number Publication Date
CN105012686A true CN105012686A (en) 2015-11-04
CN105012686B CN105012686B (en) 2018-08-31

Family

ID=54403231

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510506898.4A Active CN105012686B (en) 2015-08-18 2015-08-18 A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease

Country Status (1)

Country Link
CN (1) CN105012686B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075147A (en) * 2016-07-26 2016-11-09 马山县三和龟鳖养殖基地 Health-care feed of preventing and treating Trionyx sinensis Wiegmann hemorrhagic disease and preparation method thereof
CN107484894A (en) * 2017-09-20 2017-12-19 江西省水产科学研究所 A kind of Shelled Turtle Trionyx Sinensis resisting stress Chinese herbal feed using hooked uncaria tea as base-material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309564A (en) * 2011-07-05 2012-01-11 天津生机集团股份有限公司 Anti-stress drug used for aquatic livestock and its preparation method
KR20140091159A (en) * 2013-01-09 2014-07-21 단국대학교 산학협력단 Composition for Preventing, Treating or Improving of Andropause Syndrome comprising Lepidium meyenii extract as an Active Ingradient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309564A (en) * 2011-07-05 2012-01-11 天津生机集团股份有限公司 Anti-stress drug used for aquatic livestock and its preparation method
KR20140091159A (en) * 2013-01-09 2014-07-21 단국대학교 산학협력단 Composition for Preventing, Treating or Improving of Andropause Syndrome comprising Lepidium meyenii extract as an Active Ingradient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘凤华等: "抗蛋鸡热应激添加剂的研究进展", 《国外畜牧科技》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075147A (en) * 2016-07-26 2016-11-09 马山县三和龟鳖养殖基地 Health-care feed of preventing and treating Trionyx sinensis Wiegmann hemorrhagic disease and preparation method thereof
CN107484894A (en) * 2017-09-20 2017-12-19 江西省水产科学研究所 A kind of Shelled Turtle Trionyx Sinensis resisting stress Chinese herbal feed using hooked uncaria tea as base-material

Also Published As

Publication number Publication date
CN105012686B (en) 2018-08-31

Similar Documents

Publication Publication Date Title
CN100528211C (en) Traditional Chinese medicine for treating tumor
CN103316192B (en) Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof
CN106728770B (en) Traditional Chinese medicine composition for tonifying kidney and replenishing vital essence and preparation method thereof
CN104383515A (en) Chinese medicinal composition for treating postpartum rheumatism due to deficiency of qi and blood
CN105012686A (en) Medicinal preparation for treating stress-related diseases of Chinese soft-shelled turtles and preparing method thereof
CN104225166A (en) Chinese medicine composition for treating amenorrhea and preparation method thereof
CN105878533A (en) Chinese herbal medicine used for preventing and treating gosling plagues during anser cygnoides breeding
CN103341013B (en) A kind of Chinese medicine for the treatment of lumbago and skelalgia
CN104887958A (en) Traditional Chinese medicine preparation for treating enteritis of Chinese softshell turtles and preparation method of traditional Chinese medicine preparation
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN104161950A (en) Tendons and bones-strengthening powder and preparation method thereof
CN105055857A (en) Traditional Chinese medicine preparation for treating stress diseases of Chinese softshell turtles and preparation method of preparation
CN105998583A (en) Traditional Chinese medicine composition for treating rheumatism of dairy cows and preparation method thereof
CN101314010A (en) Liquefied clearing pill
CN104398975A (en) Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof
CN104815035A (en) Traditional Chinese medicine feed additive capable of preventing and treating postnatal anxiety of sow
CN104547474B (en) A kind of purposes of Chinese medicine preparation in treatment liver-cancer medicine is prepared
CN105311306A (en) Medicine for treating severe body odor
CN104083580A (en) Traditional Chinese medicine for treating senile dementia
CN103816388B (en) A kind of treat Chinese medicine formula of bone marrow depression that Radiotherapy chemotherapy causes and preparation method thereof
CN102846810A (en) Chinese medicinal preparation for treating threatened abortion
CN101317903A (en) Medicine for treating leucoderma and its preparation method
CN105902831A (en) Chinese medicinal pill for treatment of yin deficiency headache and preparation method thereof
Xu et al. Chinese herbal medicine
CN105055816A (en) Traditional Chinese medicine composite for treating cerebral thrombosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant